Moderna Inc
Research Moderna Inc (MRNA) on Bullrun: market cap USD 85.28B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMRNA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 85.28B
- Financial periodQ2 2026
- RevenueUSD 143.00M
- Net income-USD 782.00M
- Free cash flow-USD 563.00M
- Gross margin35.0%
Valuation Snapshot
latest market cap is USD 85.28B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.94B | -USD 2.82B | -USD 2.07B | 55.3% | -7.26 | USD 2.60B | USD 590.00M | USD 8.65B |
| FY2024 | USD 3.24B | -USD 3.56B | -USD 4.06B | 54.8% | -9.28 | USD 1.93B | USD 0 | USD 10.90B |
| FY2023 | USD 6.85B | -USD 4.71B | -USD 3.83B | 31.5% | -12.33 | USD 2.91B | USD 1.24B | USD 13.85B |
| FY2022 | USD 19.26B | USD 8.36B | USD 4.58B | 71.9% | 20.12 | USD 3.21B | USD 1.20B | USD 19.12B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 85.28B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 11.62B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 16.05B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 37.92B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 69.01B | 6.5 | n/a | n/a |
| 2021 | 2021-12-31 | USD 102.35B | 9.0 | n/a | n/a |
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines;
ETFs that hold Moderna Inc
Moderna Inc is one of the ten largest holdings of 44 ETFs that investors in Europe can buy. The 8 most traded of them:
| ETF | Weight | TER |
|---|---|---|
| Xtrackers S&P 500 Equal Weight UCITS ETF 1C | 0.58% | 0.15% |
| iShares MSCI World Small Cap UCITS ETF (USD Acc) | 0.21% | 0.35% |
| iShares S&P 500 Equal Weight UCITS ETF USD (Acc) | 0.29% | 0.15% |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF USD Acc | 1.06% | 0.43% |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 5.03% | 0.35% |
| iShares Healthcare Innovation UCITS ETF USD (Acc) | 4.90% | 0.40% |
| Amundi S&P 500 Equal Weight ESG UCITS ETF Acc | 0.47% | 0.18% |
| Xtrackers S&P 500 Equal Weight UCITS ETF 2C EUR Hedged | 0.58% | 0.30% |
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Moderna Inc's market cap?
Moderna Inc's market capitalization is USD 85.28B.
What does Moderna Inc do?
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines.